Reversion of autocrine transformation by a dominant negative platelet-derived growth factor mutant.
Open Access
- 1 July 1993
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 13 (7) , 4066-4076
- https://doi.org/10.1128/mcb.13.7.4066
Abstract
A non-receptor-binding mutant of the platelet-derived growth factor (PDGF) A chain, PDGF-0, was generated by exchanging 7 amino acids in the sequence. The mutant chains formed dimers that were similar to wild-type PDGF-AA with regard to stability and rate of processing to the mature 30-kDa secreted forms. Moreover, the mutant chains formed disulfide-bonded heterodimers with the PDGF B chain in NIH 3T3 cells heterodimer underwent the same processing and secretion as PDGF-AB. Transfection of c-sis-expressing 3T3 cells with PDGF-0 significantly inhibited the transformed phenotype of these cells, as determined by the following criteria. (i) Compared with PDGF-0-negative clones, PDGF-0-producing clones showed a reverted morphology. (ii) Clones producing PDGF-0 grew more slowly than PDGF-0-negative clones, with a fivefold difference in cell number after 14 days in culture. (iii) The expression of PDGF-0 completely inhibited the ability of the c-sis-expressing 3T3 cells to form colonies in soft agar; this inhibition was overcome by the addition of recombinant PDGF-BB to the culture medium, showing that the lack of colony formation of these cells was not due to a general unresponsiveness to PDGF. The specific expression of a PDGF-0/PDGF wild-type heterodimer in COS cells revealed that the affinity of the mutant heterodimer for the PDGF alpha receptor was decreased by approximately 50-fold compared with that of PDGF-AA. Thus, we show that a non-receptor-binding PDGF A-chain mutant neutralizes in a trans-dominant manner the autocrine transforming potential of the c-sis/PDGF B chain by forming low-affinity heterodimers with wild-type PDGF chains. This method of specifically antagonizing the effect of PDGF may be useful in investigations of the role of PDGF in normal and pathological conditions.Keywords
This publication has 53 references indexed in Scilit:
- Ligand-induced interaction between .alpha.- and .beta.-type platelet-derived growth factor (PDGF) receptors: role of receptor heterodimers in kinase activationBiochemistry, 1991
- Dominant-negative mutants of a platelet-derived growth factor gene.Genes & Development, 1990
- Selective expression of PDGF A and its receptor during early mouse embryogenesisDevelopmental Biology, 1990
- Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human plateletsBiochemistry, 1990
- A B‐type PDGF receptor lacking most of the intracellular domain escapes degradation after ligand bindingEuropean Journal of Biochemistry, 1989
- Autocrine stimulation by the v-sis gene product requires a ligand-receptor interaction at the cell surface.The Journal of cell biology, 1988
- cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell linesNature, 1986
- Antibodies against platelet-derived growth factor inhibit acute transformation by simian sarcoma virusNature, 1985
- Simian Sarcoma Virus onc Gene, v- sis , Is Derived from the Gene (or Genes) Encoding a Platelet-Derived Growth FactorScience, 1983
- Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virusNature, 1983